世界の舌癌手術のベスト医師 — TOP 36

ラルフ・ブール教授は、悪性脳腫瘍や血管奇形を含む複雑な脳神経外科症例を専門とし、広範な研究実績を持っています。

• 医学博士、47本の科学論文を発表
• 低侵襲および内視鏡下脳神経外科の専門家
• 脳腫瘍研究基金の共同設立者
• 脳転移の外科的治療で高い評価

ハサン・オズグル・オズデミル教授（医学博士）は、メディカル・パーク・アンタルヤ病院コンプレックスにて、内視鏡手術および低侵襲手術の広範なトレーニングを受けた脳神経外科医です。

• 内視鏡下脳手術および血管手術を専門とする
• 24 年以上の脳神経外科経験
• トルコ脳神経外科学会の専門医試験で1位を獲得
• トルコ脳神経外科学会およびトルコ医師会会員

タイフン・アプハン教授（医学博士）は頭頸部外科を専門とし、200以上の科学論文を発表しています。ヒサル・ホスピタル・インターコンチネンタルにて耳鼻咽喉科部門を設立しました。

• 28 年 の耳鼻咽喉科および頭頸部外科における経験
• オハイオ州立大学にて頭頸部外科の研修を修了
• 複雑な腫瘍手術および再建術を専門とする
• 耳鼻咽喉科および頭頸部疾患に関する多数の論文を発表

Hisar Hospital Intercontinentalにて頭頸部がんを専門とし、MDアンダーソンがんセンターで高度な研修を修了。

• ハジェテペ大学がん研究所でのフェローシップ経験を持つ外科腫瘍学の専門家
• 舌がん、喉頭がん、口腔がんなどの複雑な症例を治療
• トルコ屈指の医学部（ハジェテペ大学）で教育を受ける
• 多職種チームと連携し、包括的ながん治療を提供

イスタンブールのトップ病院で豊富な学術的・臨床的経験を持つ脳神経外科准教授。

• S.B. Göztepe教育研究病院にて脳神経外科を専門とする
• メディポル大学の脳神経外科部門設立に貢献
• 国際的な患者のコンサルテーションのための高度な英語力
• 現在はイスタンブール・フローレンス・ナイチンゲール病院に勤務

イマー教授は、41 年以上の脳神経外科の専門知識を舌がん手術にもたらし、機能的および定位的技術における高度なトレーニングを受けています。

• トルコ屈指の医学部であるイスタンブール大学の脳神経外科教授
• フィンランドとフランスで研修を受けた機能的脳神経外科の専門家
• 68本の論文を発表し、33の国際会議で発表
• オカン大学病院脳神経外科の創設者

スラスキー医療センター（イヒロフ）の舌がん手術を専門とする教授兼腫瘍学者。

• 外科腫瘍学における豊富な経験
• 舌がんに対する正確で効果的な治療に注力
• イスラエルの主要な医療センターに勤務

ユスフ・アチクギョズ医師は、アンカラのロクマン・ヘキム大学病院の腫瘍内科医です。肺がん、乳がん、肝臓がんなどの複雑な悪性腫瘍の治療を専門としています。米国オハイオ州立大学でフェローシップを修了しました。アチクギョズ医師は、化学療法、ラジオ塞栓療法、免疫療法などの治療を行っています。

• 米国臨床腫瘍学会（ASCO）会員。
• CheckMate-649試験を含む第III相臨床試験の補助研究員。
• オハイオ州立大学にて臨床試験実施基準（GCP）および被験者保護の認定を取得。
• 生検、胃カメラ、腫瘍マーカー検査などの診断処置を行う。

ヴィオラ・フォックス博士は、ゾーリンゲンのメディカルセンターにて、化学療法、免疫療法、標的療法を含む腫瘍疾患の包括的な治療を専門としています。

• 血液学、腫瘍学、免疫学の認定医
• がん治療のための分子生物学研究を主導
• 認定された学際的がんセンターの主任医師
• ドイツおよびアメリカの腫瘍学会会員
• 分子診断と革新的な治療法を専門とする

メディカルパーク・アンタルヤ病院コンプレックスにて、複雑な脳神経外科手術の豊富な経験を持つ脳神経外科専門医。

• 動脈瘤および脳脊髄液腫瘍の手術を専門とする
• 小児脳神経外科および脊椎手術を行う
• イスタンブール大学およびSSKギョズテペ教育病院で研修
• 迷走神経刺激に関する研究でジェンギズ・チェティン博士論文賞を受賞

准教授のタフシン・オザトリは、イスティニエ・リヴ大学病院にて乳がん、肺がん、消化器がんの治療を専門としています。

• 複数の腫瘍クリニックでの経験を持つ内科専門医
• 2016年に准教授に昇進
• セルチュク大学医学部で学ぶ

ハリル・ジャン博士は、イスティニエ大学リヴ病院トプカプの脳神経外科教授です。腫瘍や変性疾患に対する内視鏡および顕微鏡下脊椎手術を専門としています。ジャン博士は、査読付き国際論文を21本執筆しています。内視鏡による頭蓋底手術や下垂体手術など、複雑な手術を行っています。

• 脊髄損傷に対する幹細胞治療の第I相安全性試験を実施。
• 後方循環動脈瘤の81症例における外科的転帰を報告。
• 椎間板内オゾン療法やレーザー核形成術など、高度な疼痛管理の専門家。
• パーキンソン病手術や脊髄刺激装置植込み術を含む機能的脳神経外科手術を実施。

腫瘍内科を専門とするアレムダル医師は、Medical Park Antalyaにて舌がん治療に関する専門的な知見を提供しています。

• 20 年 の腫瘍学における経験
• トルコ有数の医学部であるアクデニズ大学で研修
• JCI認証を受けた高度な技術を持つ病院に勤務

カラタス医師は、ミュンヘン大学やハノーバー医科大学など、世界トップクラスの医療センターで専門的なトレーニングを受け、頭頸部外科を専門としています。

• 耳鼻咽喉科および頭頸部外科における豊富な経験
• 米国耳鼻咽喉科学会を含む、複数の権威ある医学会の会員
• ヨーロッパおよび米国で高度な技術を習得

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

複雑な症例を専門とする認定外科腫瘍医であるパストラナ医師は、ガレニア病院での舌がん手術に正確さと学術的な厳密さをもたらします。

• Centro Medico Nacional 20 de Noviembreで研修
• 2030年までConacemの認定を取得
• メキシコ腫瘍学会の正会員
• アナウアック大学で医学を指導

パナギオティス・キザス博士は、British Journal of Oral and Maxillofacial Surgeryの編集長です。エッジヒル大学の客員教授でもあります。キザス博士は毎年、何百人もの頭頸部がん患者を治療しています。英国、キプロス、ギリシャで認定された専門医です。

• 英国の権威あるBronze National Clinical Excellence Awardを受賞。
• 英国で再建外科のための3Dパーソナライズド・プランニングを導入。
• 数百万ポンド規模の臨床研究であるMANTRA試験の主任研究員を務める。
• 法学の学位（優等）を持ち、医療過誤報告を専門とする。

Gül Alço教授は、約27年の経験を持つ放射線腫瘍医です。乳がん、肺がん、前立腺がん、消化器がん、婦人科がん、中枢神経系腫瘍、頭頸部がん、軟部組織腫瘍、骨腫瘍の放射線治療を行っています。

専門分野は、適応放射線治療とラジオサージャリー（放射線外科）です。高度な放射線技術を駆使し、患者中心の多職種連携環境において、個別化された科学的根拠に基づくケアを提供しています。

アブドラ・サキン教授（Prof. Dr. Abdullah Sakin）は、腫瘍内科の教授です。肺がん、乳がん、消化器がん、泌尿器がん、婦人科がん、頭頸部がん、悪性黒色腫（メラノーマ）などの固形腫瘍を専門としています。

科学的根拠に基づいた個別化医療を提供しています。治療法には、化学療法、分子標的療法、免疫療法、ホルモン療法、精密腫瘍学（プレシジョン・オンコロジー）が含まれます。200本以上の科学論文を執筆しており、国際的な臨床研究にも積極的に参加しています。これらの活動は、患者中心のがん医療の発展に寄与しています。